Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2023-07-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically issued shares, share options, and other related share capital information for China Resources Pharmaceutical Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows a regulatory format (FF301) for reporting share capital movements under Chapter 19B of the Exchange Listing Rules. The document does not contain financial statements, earnings data, or management discussion but focuses on share capital changes and confirmations related to share issuance and options. This type of document is a regulatory filing related to share capital movements but does not announce a new share issue or capital change event itself, nor is it a full financial report or earnings release. It fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory reports that do not fit other specific categories.
2023-07-03 English
DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
Notice of Dividend Amount Classification · 100% confidence The document is a Dividend Currency Election Form for the final dividend for the year ended 31 December 2022. It provides shareholders with options to elect the currency in which they wish to receive their dividend payments (Hong Kong Dollars or Renminbi). The document includes instructions on how to complete and return the form, notes on the election process, and personal data collection statements. It is not a financial report, earnings release, or announcement of voting results. It is a shareholder communication related to dividend payment options, which fits best under the category of Notice of Dividend Amount (DIV), as it relates directly to dividend payment details and shareholder instructions for dividend receipt.
2023-06-14 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document is a list of directors and their roles and functions for China Resources Pharmaceutical Group Limited, including details about board committees and membership. It does not contain financial data, audit information, or regulatory filings. It is not an announcement of voting results or a report of share transactions. The content is focused on board and management information, specifically the composition and roles of the board of directors and committees. The document length is short (2188 characters) and contains no financial statements or report references. Therefore, it fits best under Board/Management Information (MANG).
2023-06-13 English
RESIGNATION OF EXECUTIVE DIRECTOR,VICE PRESIDENT AND BOARD COMMITTEES' MEMBER AND AUTHORIZED REPRESENTATIVE AND APPOINTMENT OF CHIEF FINANCIAL OFFICER AND CHANGE OF COMPANY SECRETARY AND AUTHORIZ
Board/Management Information Classification · 100% confidence The document is an announcement from the Board of China Resources Pharmaceutical Group Limited regarding the resignation and appointment of key company officers including an executive director, chief financial officer, company secretary, and authorized representatives. It details personnel changes and biographical information of the new appointees. There are no financial statements, earnings data, or detailed financial analysis present. The document is not a full annual or interim report, nor is it a call transcript or investor presentation. It is clearly a management/board announcement about changes in senior management and board committees. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (7471 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-06-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically issued shares, share options, and other related share capital information for China Resources Pharmaceutical Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows a prescribed form (FF301) related to Chapter 19B of the Exchange Listing Rules. The content focuses on share capital movements, share options, and confirmations related to securities, without any financial performance data, earnings, or management commentary. It is not an annual or interim report, earnings release, or management discussion. It is a regulatory filing reporting share capital and securities movements as required by the exchange rules. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-06-01 English
ANNUAL GENERAL MEETING HELD ON 29 MAY 2023 POLL RESULTS
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from the Annual General Meeting (AGM) held on 29 May 2023. It details the voting outcomes on various resolutions including receiving the audited financial statements, re-election of directors, appointment of auditors, and mandates related to share buybacks and issuance. The document does not contain the full financial report or detailed financial statements but rather the official voting results from the AGM. It references the Circular for more details and provides links to the company and stock exchange websites for the full documents. The length is about 6922 characters, which is consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-05-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.